A 12-Week, double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of APD356 in Obese Patients

Status	Finished
Effective start/end date	7/1/05 → 10/31/06

Grants and Contracts Details